What is antitrust clearance?
Antitrust clearance is the approval from competition regulators that a merger or acquisition may proceed without unduly harming competition. For deals above certain size thresholds, the parties must notify the relevant authorities and wait for clearance before they can legally complete the transaction.
In the United States this runs through the Hart-Scott-Rodino premerger notification process, reviewed by the Federal Trade Commission and the Department of Justice; the European Union, the United Kingdom, and dozens of other jurisdictions run parallel regimes. A large cross-border deal may need clearance from many regulators at once.
Clearance is a condition to closing, not a formality. The regulator can approve the deal, approve it subject to remedies such as divestitures or behavioral commitments, or move to block it. Until clearance is obtained, the parties must continue operating as independent competitors.
How the clearance process works
The process is staged, with most deals clearing early and only the competitively significant ones proceeding to deeper review.
- Notification. If the deal exceeds the size thresholds, the parties file premerger notifications and pay the applicable fees.
- Initial waiting period. A statutory clock runs — 30 days under HSR, for example — during which the parties cannot close. Most deals clear here.
- Second request / Phase 2. If the regulator has concerns, it issues a demand for extensive additional information, pausing the clock and triggering a deep, expensive review.
- Outcome. The regulator clears the deal, clears it with remedies (divesting overlapping assets or accepting conduct commitments), or sues to block it.
Throughout, the parties remain separate competitors. Coordinating prices, integrating operations, or exchanging competitively sensitive information before clearance is gun-jumping and is itself unlawful — which is why clean teams are used during diligence of competitor targets.
Why clearance shapes the deal, not just the timeline
Antitrust risk is priced into deals from the start. Where there is meaningful overlap, the parties negotiate which side bears the risk — through a reverse termination fee the buyer pays if the deal is blocked, and through covenants about how hard the buyer must fight or what divestitures it must accept to win clearance.
The review can also reshape the asset. A regulator may clear the deal only if the buyer divests an overlapping business, meaning the company that emerges is smaller than the one signed for. For deals in concentrated markets, the antitrust analysis is part of the underwriting from day one, not an afterthought at closing.